4//SEC Filing
Bellevue Global Life Science Investors LLC 4
Accession 0000899243-23-005297
CIK 0001840425other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 7:52 PM ET
Size
26.5 KB
Accession
0000899243-23-005297
Insider Transaction Report
Form 4
Transactions
- Award
Common Stock
2023-02-14$10.00/sh+430,000$4,300,000→ 1,800,000 total - Other
Common Stock
2023-02-14−20,000→ 1,705,000 total - Other
Common Stock
2023-02-14−225,000→ 1,400,000 total - Other
Common Stock
2023-02-14−30,000→ 1,370,000 total - Purchase
Private Placement Warrants
2023-02-14$10.00/sh+430,000$4,300,000→ 430,000 totalExercise: $11.50→ Common Stock (430,000 underlying) - Other
Warrant for Common Stock
2023-02-14−20,000→ 410,000 totalExercise: $11.50→ Common Stock (20,000 underlying)
Footnotes (12)
- [F1]Represents shares of common stock held by Bellevue Global Life Sciences Investors LLC, the sponsor of the Issuer (the "Sponsor") whose general partner is Bellevue Capital Management LLC ("Bellevue Capital"). Kuk Hyoun Hwang is the managing partner of Bellevue Capital and has voting and dispositive power over the shares held by the Sponsor.
- [F10]The Sponsor purchased an aggregate of 430,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement that occurred simultaneously with the consummation of the Issuer's Public Offering. Each Private Placement Unit consists of one share of Common Stock, one redeemable warrant entitling the holder to purchase one share of Common Stock, and one right which entitles the holder thereof to receive one-tenth (1/10) of a share of common stock. The Private Placement Warrants are exercisable only to purchase whole shares of Common Stock at an exercise price of $11.50 per share, subject to adjustments. Each warrant will become exercisable 30 days after the Issuer's Public Offering. Each warrant will expire five years after the completion of the Issuer's Public Offering, or earlier upon redemption or liquidation.
- [F11]Represents the warrant to purchase a total of 20,000 shares of the Issuer, transferred from the Sponsor to Dr. In Chul Chung for his service as Chairman of the Audit Committee.
- [F12]Represents the warrant to purchase a total of 20,000 shares of the Issuer, transferred from the Sponsor to Mr. Steven Reed for his service as Chairman of the Board of Directors.
- [F2]Represents the shares transferred by the Sponsor to Mr. Jin Whan Park for his board service.
- [F3]Represents the shares transferred by the Sponsor to Mr. Steven Reed for his board service.
- [F4]Represents the shares transferred by the Sponsor to Mr. In Chul Chung for his board service.
- [F5]Represents the shares transferred by the Sponsor to Mr. Husun Euh for his board service.
- [F6]Represents the shares transferred by the Sponsor to Mr. Rad Roberts for his board service.
- [F7]Represents the shares that were forfeited as a result of the underwriters' not exercising their over-allotment option.
- [F8]Represents the shares transferred by the Sponsor to the underwriters.
- [F9]The Sponsor purchased an aggregate of 430,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement that occurred simultaneously with the consummation of the Issuer's Public Offering. Each Private Placement Unit consists of one share of Common Stock, one redeemable warrant entitling the holder to purchase one share of Common Stock, and one right which entitles the holder thereof to receive one-tenth (1/10) of a share of common stock.
Documents
Issuer
Bellevue Life Sciences Acquisition Corp.
CIK 0001840425
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001953768
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 7:52 PM ET
- Size
- 26.5 KB